Vincent Richard G
- SEC CIK
- 0001269341
No open-market purchases or sales filed in the past year.
Current role at each company
- FBRX Forte Biosciences, Inc.Directoras of Aug 27, 2026
- ONCT Oncternal Therapeutics, Inc.Chief Financial Officeras of Feb 15, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vincent Richard G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ONCT Oncternal Therapeutics, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 (view filing)6:00 AM ET | Apr 13 | 1 day | Vincent Richard GChief Financial Officer | PPurchase | +30.0K | $0.2987 | +$8.96K | +23.6%156.9K after | |
| Mar 28, 2022 (view filing) | Mar 24-28 | 4 days | Vincent Richard GChief Financial Officer | PPurchase | +5.00K | $1.44 | +$7.21K | +6.0%88.2K after | 5 lots |
| Jan 31, 2022 (view filing) | Jan 27-28 | 4 days | Vincent Richard GChief Financial Officer | PPurchase | +12.5K | $1.73 | +$21.6K | +17.7%83.2K after | 3 lots |